<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04981496</url>
  </required_header>
  <id_info>
    <org_study_id>20HH5882</org_study_id>
    <secondary_id>FS/20/11/34750</secondary_id>
    <nct_id>NCT04981496</nct_id>
  </id_info>
  <brief_title>Novel ICD Arrhythmia Detection Algorithm</brief_title>
  <official_title>Improving Implantable Cardioverter-defibrillator Arrhythmia Detection: Development of a Novel Arrhythmia Detection Algorithm</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Imperial College London</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Implantable cardioverter defibrillators (ICD) are used to treat life-threatening heart rhythm&#xD;
      disturbances (arrhythmias).&#xD;
&#xD;
      They have been proven to reduce the risk of sudden cardiac deathÍ¾ however, there are&#xD;
      limitations with current ICDs. Firstly, they may deliver inappropriate therapies (therapies&#xD;
      delivered in the absence of life-threatening arrhythmias). Secondly, slower life-threatening&#xD;
      arrhythmias may be left untreated because current programming recommendations, designed to&#xD;
      minimise inappropriate therapies, rely predominantly on heart rates. Therefore, there is&#xD;
      considerable potential to make ICDs safer with more sophisticated ICD algorithms.&#xD;
&#xD;
      In this research study we will collect data from patients with newly implanted or existing&#xD;
      ICDs whilst they are in induced or spontaneously occurring abnormal rhythms. The data will&#xD;
      come from sensors placed on the skin that can measure blood flow or electrical properties of&#xD;
      the body. In addition, in 20 patients we will also collect further data from a small loop&#xD;
      recorder implanted under the skin.&#xD;
&#xD;
      We will use this data to help develop and validate new methods of reliably identifying&#xD;
      life-threatening arrhythmias so that future ICDs deliver therapies when only needed.&#xD;
&#xD;
      The research is funded by the British Heart Foundation, and will take place at Hammersmith&#xD;
      Hospital over 3 years. We aim to recruit 100 patients in total.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This novel arrhythmia detection algorithm will incorporate a haemodynamic sensor and extra&#xD;
      bipolar electrogram with an aim to outperform current commercially used arrhythmia detection&#xD;
      algorithms that rely primarily on heart rate.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 6, 2021</start_date>
  <completion_date type="Anticipated">October 7, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Outperforming current arrhythmia detection algorithms</measure>
    <time_frame>3 years</time_frame>
    <description>Improvement in sensitivity and specificity in accurately detecting ventricular arrhythmias in comparison to current algorithms. sensor and a separate electrical signal can out-perform current implantable cardioverter defibrillator algorithms.&#xD;
We will run different simulated and genuine arrhythmias through our novel detection algorithm and compare it against detection algorithms from all the major manufacturers with devices programmed as per HRS primary prevention guidelines.</description>
  </primary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>ICD</condition>
  <condition>Implantable Defibrillator User</condition>
  <condition>Cardiomyopathies</condition>
  <arm_group>
    <arm_group_label>Study A: ILR implantation</arm_group_label>
    <description>These are participants attending hospital for a clinically indicated ICD/CRT-D implantation or box change who will undergo rapid atrial and ventricular pacing to simulate arrhythmias and RV lead noise simulation and have an ILR implanted during their procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Study B: ICD implantation</arm_group_label>
    <description>These are participants attending hospital for a clinically indicated ICD/CRT-D implantation or box change who will undergo rapid atrial and ventricular pacing to simulate arrhythmias and RV lead noise simulation who will not have an ILR implanted.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Study C: VT Ablation</arm_group_label>
    <description>These are participants having a clinically indicated VT ablation who we will record ventricular arrhythmias during the procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Study D: Exercise Treadmill Test</arm_group_label>
    <description>These are participants who already have a cardioverter defibrillator implanted who can safely exercise and bring up their heart rate.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Study E: Spontaneous Arrhythmias</arm_group_label>
    <description>These are participants who already have a cardioverter defibrillator implanted and come into hospital with an atrial or ventricular arrhythmia.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Study A and B Patients who are having a clinically indicated ICD implantation or its&#xD;
        battery replaced.&#xD;
&#xD;
        Study C Patients who already have an ICD implanted and are undergoing a clinically&#xD;
        indicated VT ablation.&#xD;
&#xD;
        Study D Patients who already have an ICD implanted and are able to safely raise their heart&#xD;
        rates through exercise.&#xD;
&#xD;
        Study E Patients who already have an ICD implanted and attend hospital with a spontaneous&#xD;
        arrhythmia.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Study A and B&#xD;
&#xD;
          1. Patients referred for conventional defibrillator implantation or generator change.&#xD;
&#xD;
          2. Adults (age &gt; 18 years)&#xD;
&#xD;
          3. Willing to take part and able to give consent.&#xD;
&#xD;
        Study C&#xD;
&#xD;
          1. Patients with defibrillators who are undergoing a VT ablation.&#xD;
&#xD;
          2. Adults (age &gt; 18 years)&#xD;
&#xD;
          3. Willing to take part and able to give consent.&#xD;
&#xD;
        Study D&#xD;
&#xD;
          1. Patients with defibrillators already implanted who are able to exercise and raise&#xD;
             their heart rate substantially&#xD;
&#xD;
          2. Adults (age &gt; 18 years)&#xD;
&#xD;
          3. Willing to take part and able to give consent.&#xD;
&#xD;
        Study E&#xD;
&#xD;
          1. Patients with a defibrillator already implanted admitted with atrial arrhythmias,&#xD;
             ventricular tachycardia or RV lead fracture.&#xD;
&#xD;
          2. Adults (age &gt; 18 years)&#xD;
&#xD;
          3. Willing to take part and able to give consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Exclusion criteria for studies A-E:&#xD;
&#xD;
          1. Unable to give consent.&#xD;
&#xD;
          2. Children (age &lt; 18 years)&#xD;
&#xD;
          3. Pregnant women.&#xD;
&#xD;
        Exclusion criteria for studies A and B if undergoing VF induction:&#xD;
&#xD;
          1. Intracardiac thrombus&#xD;
&#xD;
          2. AF without regular anticoagulation&#xD;
&#xD;
          3. Severe aortic stenosis&#xD;
&#xD;
          4. Severe ischaemic heart disease&#xD;
&#xD;
          5. Decompensated heart failure&#xD;
&#xD;
        Exclusion criteria for study D&#xD;
&#xD;
          1. Recent heart attack or stroke (within the last month)&#xD;
&#xD;
          2. Thromboembolic event undergoing active treatment&#xD;
&#xD;
          3. Severe aortic stenosis&#xD;
&#xD;
          4. Severe ischaemic heart disease&#xD;
&#xD;
          5. Hypertrophic obstructive cardiomyopathy&#xD;
&#xD;
          6. Uncontrolled ventricular arrhythmias&#xD;
&#xD;
          7. Physically unable to exercise, for example due to arthritis.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Alejandra A Miyazawa, MBChB</last_name>
    <phone>07511002203</phone>
    <email>a.miyazawa@imperial.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zachary I Whinnett</last_name>
    <phone>0203 313 3000</phone>
    <email>z.whinnett@imperial.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hammersmith Hospital</name>
      <address>
        <city>London</city>
        <zip>W12 0HS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alejandra A Miyazawa, MBChB</last_name>
      <phone>0203 313 36760</phone>
      <phone_ext>36760</phone_ext>
      <email>a.miyazawa@imperial.ac.uk</email>
    </contact>
    <contact_backup>
      <last_name>Zachary I Whinnett</last_name>
      <email>z.whinnett@imperial.ac.uk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 19, 2021</study_first_submitted>
  <study_first_submitted_qc>July 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 29, 2021</study_first_posted>
  <last_update_submitted>July 19, 2021</last_update_submitted>
  <last_update_submitted_qc>July 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ICD</keyword>
  <keyword>arrhythmia</keyword>
  <keyword>algorithm</keyword>
  <keyword>haemodynamic sensor</keyword>
  <keyword>bipolar electrogram</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

